Navigation Links
Bionovo Receives Positive Guidance from FDA on Menerba®
Date:8/30/2010

es, prior to clinical dosing, Bionovo will complete a 28 day bioequivalence study in rats. The agency also requested that Bionovo provide selected batch records for review. It is important to remember that Menerba was effective in Phase 2 and showed no signs of safety concerns in human or animal studies to date."

"With the CMC preparations complete, we can now turn our attention to finalizing the communication on the clinical trial design with the FDA in the coming weeks," said Mary Tagliaferri, M.D., Bionovo's President and Chief Medical Officer. "We expect to be able to initiate pivotal trials by year end."

Previously, the Company received final guidance from the European Medicines Agency (EMA) in order to advance Menerba to Phase 3 clinical trials in Europe. The EMA guidance defines the clinical and regulatory pathway to a European marketing authorization for Menerba. With this EMA guidance, and the FDA guidance, the Company is now preparing for pivotal clinical trials in the U.S. and Europe.

About Menerba

Menerba is an oral, botanical-derived drug candidate designed for the safe, effective treatment of vasomotor symptoms (hot flashes) associated with menopause. Menerba is an estrogen receptor beta (ER-b) selective drug, developed as an alternative to the products currently on the market, which have been shown to increase the risk for breast and uterine cancers. Clinical tests conducted thus far, following the specific guidance of the FDA, have indicated that Menerba is effective and safe.

About Bionovo, Inc.

Bionovo is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Bionovo Announces Reverse Stock Split
2. Bionovo Announces Publication Describing Menerbas Effect on Neural Pathways Related to Temperature Regulation
3. Bionovo to Advance Menerba to Phase 3 Clinical Testing in Europe
4. Bionovo, Inc. to Announce Second Quarter Fiscal Year 2010 Financial Results on Wednesday, August 4, 2010
5. Bionovo Announces a $15 Million At-The-Market Firm Commitment Financing Agreement
6. Bionovo Announces 2009 Highlights and Year-End Financial Results
7. Bionovo, Inc. to Announce Fourth Quarter and Fiscal Year 2009 Financial Results on Monday, March 15, 2010
8. Bionovo Announces Publication of Positive Results From the Phase 1B Clinical Trial of Bezielle (BZL101) for Metastatic Breast Cancer
9. Bionovo Announces Third Quarter 2009 Highlights and Financial Results
10. Bionovo, Inc. to Announce Third Quarter Fiscal Year 2009 Financial Results on Thursday, November 5, 2009
11. Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Receptor Beta
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... YORK, Pa. , Aug. 29, 2014  Unilife ...  ASX: UNS) announced today that it intends to release ... and year ended June 30, 2014 after market trading ... Management has scheduled a conference call for 4:30 p.m. ... 10, 2014 at 6:30 a.m. AEST), to review the Company,s ...
(Date:8/29/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... consumables to the medical, research and veterinary markets, announced ... Executive Officer, will present at the CL King 12 ... September 9, 2014 at 12:30 p.m. ET. The conference ... in New York City . ...
(Date:8/29/2014)... 2014 Research and Markets  has announced ... Repair Devices Market 2014-2018" report to their offering. ... of cells that connect, support, or surround bones. There ... tendons, ligaments, cartilage, fascia, and other fibrous tissues. Repetitive ... with age result in wear and tear in these ...
Breaking Medicine Technology:Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 3
... Oct. 7 Marine biotechnology specialist Azantis, Inc ... to its clients, in an effort to provide continued ... an agreement with SafetyCall International , Azantis has ... and Post-Market Surveillance services. SafetyCall medical ...
... Oct. 7 Spherix Incorporated (Nasdaq: ... in diabetes, metabolic syndrome and atherosclerosis; and providers of ... and pharmaceutical companies, today announced that it has entered ... its Series B Convertible Preferred Stock and warrants to ...
Cached Medicine Technology:Azantis Announces New Consumer Safety Program 2Spherix Announces Institutional Investors Purchase $5.25 Million of Convertible Preferred Stock and Warrants 2Spherix Announces Institutional Investors Purchase $5.25 Million of Convertible Preferred Stock and Warrants 3
(Date:9/2/2014)... 02, 2014 NOVAtime Technology, Inc. ... development company, announced today that Avon Health Center, ... upgraded to NOVAtime 4000 Time and Attendance ... NOVAtime’s latest smart clock, the NT7000 . ... of Connecticut is an award-winning nursing facility that ...
(Date:9/2/2014)... VA (PRWEB) September 02, 2014 During ... important to prepare for the winter months to prevent ... Northern Virginia real estate company, suggests these fall ... Clean gutters and downspouts frequently throughout fall to prevent ... can lead to wood rot problems, pest infestations, wet ...
(Date:9/1/2014)... September 02, 2014 Citrus Park ... root canal therapy based in Tampa, Florida, announced the ... features helpful information aimed at making the patient experience ... eye-catching design featuring updated images that truly make the ... our website experience just as pleasant as our office ...
(Date:9/1/2014)... September 02, 2014 PAINWeek, the National ... the American Pain Society (APS) will return to the ... expertise in pain management to the agenda. This activity ... no fee to attend this program. , On Thursday, ... activity that complies with the FDA’s Risk Evaluation and ...
(Date:9/1/2014)... September 02, 2014 UWDress.com, a well-known ... of 2014 lime green bridesmaid dresses for ... been added to the company’s online category. What’s more, ... 67% off. The special offer is specially launched to ... UWDress.com’s fashionable bridesmaid gowns have won great appreciation from ...
Breaking Medicine News(10 mins):Health News:Avon Healthcare Upgrades to NOVAtime 4000 Time and Attendance / Workforce Management Solution with NT7000 Smart Clocks 2Health News:Avon Healthcare Upgrades to NOVAtime 4000 Time and Attendance / Workforce Management Solution with NT7000 Smart Clocks 3Health News:Northern Virginia Real Estate Company Pasquali Realty Group Suggests These Maintenance Tips for Homeowners This Fall 2Health News:Citrus Park Endodontics Launches New Website to Better Serve Patients 2Health News:American Pain Society Returns with REMS Training at PAINWeek 2014 in Las Vegas 2Health News:2014 Lime Green Bridesmaid Dresses Offered At UWDress.com 2
... their families living with ... all types of epilepsy, ... series "Heroes" and father of an 11-year-old son with,epilepsy - joined ... community awareness activities that will empower other,people living with the condition. ...
... WASHINGTON, March 27 SEIU Spokesperson,Andrew ... members, resources, UHW-W leaders should focus ... contracts this year. UHW-W members,deserve better ... at risk by a distracted,UHW-W leadership.", ...
... DENVER, March 27 On March 25, 2008, ... the Gadolinium-Based Contrast,Agents Product Liability Multi-District Litigation in ... serve on the Plaintiffs, Steering,Committee. One of these ... PSC,reports directly to Judge Polster, and is responsible ...
... preferred it to product requiring three injections a day ... that a once-daily shot of insulin appears to control ... just as well as injecting insulin three times a ... (Lantus), is already on the market, as is insulin ...
... Ill., March 27 Lifeway Foods,Inc. (Nasdaq: LWAY ... of other natural and organic dairy products, is opening ... Starfruit in Chicago. The,shop will offer several flavors of ... kefir parfaits, and smoothie-style kefir drinks., The new ...
... you know that teledentistry can help provide orthodontic treatment ... provide diagnostic clues to your systemic health? Have you ... growth with other metabolic processes?, These are but a ... will be presented when the American Association for Dental ...
Cached Medicine News:Health News:Once-Daily Insulin Shot Proves Effective in Study 2Health News:Once-Daily Insulin Shot Proves Effective in Study 3Health News:Lifeway Foods Launches Starfruit, New 'Kefir Boutique' Cafe Selling Frozen Kefir & Kefir Smoothies 2Health News:Dental scientists convene in Dallas 2Health News:Dental scientists convene in Dallas 3Health News:Dental scientists convene in Dallas 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: